|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Joachim C, Macni J, Drame M, Pomier A,
Escarmant P, Veronique-Baudin J and Vinh-Hung V: Overall survival
of colorectal cancer by stage at diagnosis: Data from the
Martinique Cancer Registry. Medicine (Baltimore).
98(e16941)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Diao F and Cai S: Aspirin-based
chemoprevention of colorectal cancer: The role for gut microbiota.
Cancer Commun (Lond). 40:633–635. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang Y, Lin R, Ling H, Ke Y, Zeng Y, Xiong
Y, Zhou Q, Zhou F and Zhou Y: Dual inhibition of CDK4 and FYN leads
to selective cell death in KRAS-mutant colorectal cancer. Signal
Transduct Target Ther. 4(52)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu S, Lin H, Wang D, Li Q, Luo H, Li G,
Chen X, Li Y, Chen P, Zhai B, et al: PCDH17 increases the
sensitivity of colorectal cancer to 5-fluorouracil treatment by
inducing apoptosis and autophagic cell death. Signal Transduct
Target Ther. 4(53)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yu D, Han GH, Zhao X, Liu X, Xue K, Wang D
and Xu CB: MicroRNA-129-5p suppresses nasopharyngeal carcinoma
lymphangiogenesis and lymph node metastasis by targeting ZIC2. Cell
Oncol (Dordr). 43:249–261. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jacob H, Stanisavljevic L, Storli KE,
Hestetun KE, Dahl O and Myklebust MP: Identification of a
sixteen-microRNA signature as prognostic biomarker for stage II and
III colon cancer. Oncotarget. 8:87837–87847. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Zhuo ZJ, Zhou H, Liu J, Xiao Z, Xiao
Y, He J and Liu Z: miR-34b/c rs4938723 T>C decreases
neuroblastoma risk: A replication study in the hunan children. Dis
Markers. 2019(6514608)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li S, Wu X, Xu Y, Wu S, Li Z, Chen R,
Huang N, Zhu Z and Xu X: miR-145 suppresses colorectal cancer cell
migration and invasion by targeting an ETS-related gene. Oncol Rep.
36:1917–1926. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Huang W, Yan Y, Liu Y, Lin M, Ma J, Zhang
W, Dai J, Li J, Guo Q, Chen H, et al: Exosomes with low miR-34c-3p
expression promote invasion and migration of non-small cell lung
cancer by upregulating integrin α2β1. Signal Transduct Target Ther.
5(39)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Slattery ML, Herrick JS, Pellatt DF,
Stevens JR, Mullany LE, Wolff E, Hoffman MD, Samowitz WS and Wolff
RK: MicroRNA profiles in colorectal carcinomas, adenomas and normal
colonic mucosa: Variations in miRNA expression and disease
progression. Carcinogenesis. 37:245–261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hu Y, Zhang Q, Cui J, Liao ZJ, Jiao M,
Zhang YB, Guo YH and Gao YM: Oncogene miR-934 promotes ovarian
cancer cell proliferation and inhibits cell apoptosis through
targeting BRMS1L. Eur Rev Med Pharmacol Sci. 23:5595–5602.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Saad MA, Kuo SZ, Rahimy E, Zou AE,
Korrapati A, Rahimy M, Kim E, Zheng H, Yu MA, Wang-Rodriguez J and
Ongkeko WM: Alcohol-dysregulated miR-30a and miR-934 in head and
neck squamous cell carcinoma. Mol Cancer. 14(181)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hirata H, Hinoda Y, Nakajima K, Kawamoto
K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, et
al: Wnt antagonist gene DKK2 is epigenetically silenced and
inhibits renal cancer progression through apoptotic and cell cycle
pathways. Clin Cancer Res. 15:5678–5687. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zheng YB, Xiao K, Xiao GC, Tong SL, Ding
Y, Wang QS, Li SB and Hao ZN: MicroRNA-103 promotes tumor growth
and metastasis in colorectal cancer by directly targeting LATS2.
Oncol Lett. 12:2194–2200. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhao D, Ma Y, Li X and Lu X: microRNA-211
promotes invasion and migration of colorectal cancer cells by
targeting FABP4 via PPARγ. J Cell Physiol: Feb 26, 2019. doi:
10.1002/jcp.28190. (Epub ahead of print).
|
|
21
|
Zhang Z, Zhong X, Xiao Y and Chen C:
MicroRNA-296 inhibits colorectal cancer cell growth and enhances
apoptosis by targeting ARRB1-mediated AKT activation. Oncol Rep.
41:619–629. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yan H, Ren S, Lin Q, Yu Y, Chen C, Hua X,
Jin H, Lu Y, Zhang H, Xie Q, et al: Inhibition of UBE2N-dependent
CDK6 protein degradation by miR-934 promotes human bladder cancer
cell growth. FASEB J. 33:12112–12123. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen G, Gao C, Gao X, Zhang DH, Kuan SF,
Burns TF and Hu J: Wnt/β-catenin pathway activation mediates
adaptive resistance to BRAF inhibition in colorectal cancer. Mol
Cancer Ther. 17:806–813. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bahrami A, Amerizadeh F, ShahidSales S,
Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, Maftouh M, Hassanian
SM and Avan A: Therapeutic potential of targeting Wnt/β-catenin
pathway in treatment of colorectal cancer: Rational and progress. J
Cell Biochem. 118:1979–1983. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kleszcz R, Szymanska A, Krajka-Kuzniak V,
Baer-Dubowska W and Paluszczak J: Inhibition of CBP/β-catenin and
porcupine attenuates Wnt signaling and induces apoptosis in head
and neck carcinoma cells. Cell Oncol (Dordr). 42:505–520.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhu J, Zhang S, Gu L and Di W: Epigenetic
silencing of DKK2 and Wnt signal pathway components in human
ovarian carcinoma. Carcinogenesis. 33:2334–2343. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kawakita A, Yanamoto S, Yamada S, Naruse
T, Takahashi H, Kawasaki G and Umeda M: MicroRNA-21 promotes oral
cancer invasion via the Wnt/β-catenin pathway by targeting DKK2.
Pathol Oncol Res. 20:253–261. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Deng F, Zhou R, Lin C, Yang S, Wang H, Li
W, Zheng K, Lin W, Li X, Yao X, et al: Tumor-secreted dickkopf2
accelerates aerobic glycolysis and promotes angiogenesis in
colorectal cancer. Theranostics. 9:1001–1014. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sun LY, Bie ZD, Zhang CH, Li H, Li LD and
Yang J: MiR-154 directly suppresses DKK2 to activate Wnt signaling
pathway and enhance activation of cardiac fibroblasts. Cell Biol
Int. 40:1271–1279. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wu X, Gu Q, Chen X, Mi W, Wu T and Huang
H: MiR-27a targets DKK2 and SFRP1 to promote reosseointegration in
the regenerative treatment of peri-implantitis. J Bone Miner Res.
34:123–134. 2019.PubMed/NCBI View Article : Google Scholar
|
